Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PAR.NSthis companyPar Drugs and Chemicals Limited	₹113.17	7.38×	0.86×	0.93×	2.6×	186.5%	48.7%	13.0%	12.6%	11.7%	8.8%	15.0%	0×	-1.98×	105.48×	4.68×	0.0%	4	5.87	4	A
ACHYUT.BOAchyut Healthcare Ltd.	₹8.09	532.32×	3.54×	17.22×	264.63×	-352.1%	16.8%	1.2%	3.3%	0.7%	0.2%	-5.6%	0.04×	-3.9×	30.1×	4.59×	0.0%	5	23.86	2	C+
BABALPHARMA.BOBal Pharma Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BALPHARMA.NSBal Pharma Limited	₹83.18	15.3×	1.17×	0.31×	7.34×	72.1%	24.4%	6.7%	2.0%	7.6%	8.2%	-4.2%	1.94×	4.5×	1.24×	1.05×	2.0%	2	—	2	C+
DENISCHEM.BODenis Chem Lab Limited	₹59.95	9.33×	0.86×	0.43×	4.2×	21.6%	33.0%	6.0%	4.6%	9.2%	7.9%	1.9%	0.05×	0.19×	12.86×	2.7×	2.7%	5	4.36	2	C
KRKREBSBIO.BOKrebs Biochemicals & Industries Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	15.3×	1.17×	0.43×	7.34×	21.6%	24.4%	6.0%	3.3%	7.6%	7.9%	-4.2%	0.05×	0.19×	12.86×	2.7×	2.0%	5	14.11	2	—